| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PNAS..109E3473T |
| P356 | DOI | 10.1073/PNAS.1202637109 |
| P932 | PMC publication ID | 3528537 |
| P698 | PubMed publication ID | 23161911 |
| P5875 | ResearchGate publication ID | 233539140 |
| P50 | author | Chi Man Tsang | Q90584750 |
| Ka Fai To | Q99551275 | ||
| P2093 | author name string | Kenzo Takada | |
| Wen Deng | |||
| Maria Li Lung | |||
| Sai Wah Tsao | |||
| Honglin Chen | |||
| Kwok Wai Lo | |||
| Annie Lai-Man Cheung | |||
| Musheng Zeng | |||
| Pok Man Hau | |||
| Yim Ling Yip | |||
| Vivian Wai Yan Lui | |||
| Jaap Michiel Middeldorp | |||
| Victoria Ming Yi Lau | |||
| P2860 | cites work | Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches | Q29036707 |
| Epstein-Barr virus: 40 years on | Q29617969 | ||
| Influenza A Virus Replication Induces Cell Cycle Arrest in G 0 /G 1 Phase | Q30394001 | ||
| Murine coronavirus replication induces cell cycle arrest in G0/G1 phase. | Q34151707 | ||
| Cyclin D1 downregulation is important for permanent cell cycle exit and initiation of differentiation induced by anchorage-deprivation in human keratinocytes | Q34331020 | ||
| Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression | Q34549944 | ||
| Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo | Q34553645 | ||
| Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions | Q34576340 | ||
| Epstein-Barr virus in the pathogenesis of NPC. | Q35008870 | ||
| Genetic and epigenetic changes in nasopharyngeal carcinoma. | Q35008876 | ||
| The significance of LMP1 expression in nasopharyngeal carcinoma | Q35008886 | ||
| Cyclin D1 expression is regulated by the retinoblastoma protein | Q35145847 | ||
| Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion | Q35652539 | ||
| Focus on nasopharyngeal carcinoma | Q35773862 | ||
| The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors | Q35851139 | ||
| Human T-cell leukemia virus type 1 infection leads to arrest in the G1 phase of the cell cycle | Q36845774 | ||
| Host shutoff is a conserved phenotype of gammaherpesvirus infection and is orchestrated exclusively from the cytoplasm | Q37333940 | ||
| The interferon system and vaccinia virus evasion mechanisms | Q37587172 | ||
| The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). | Q37976235 | ||
| The biology of EBV infection in human epithelial cells | Q38002035 | ||
| Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma | Q38480025 | ||
| Reconstitution of cyclin D1-associated kinase activity drives terminally differentiated cells into the cell cycle | Q39460727 | ||
| Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization. | Q39749474 | ||
| Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification | Q39852028 | ||
| The Epstein-Barr virus replication and transcription activator, Rta/BRLF1, induces cellular senescence in epithelial cells. | Q39903181 | ||
| Molecular and cytogenetic changes involved in the immortalization of nasopharyngeal epithelial cells by telomerase | Q40281326 | ||
| Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma | Q40372899 | ||
| Epstein-Barr virus-encoded poly(A)- RNA confers resistance to apoptosis mediated through Fas by blocking the PKR pathway in human epithelial intestine 407 cells. | Q40373897 | ||
| Determining the role of the Epstein-Barr virus Cp EBNA2-dependent enhancer during the establishment of latency by using mutant and wild-type viruses recovered from cottontop marmoset lymphoblastoid cell lines | Q40843617 | ||
| The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells | Q41112391 | ||
| Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma. | Q41246787 | ||
| Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo | Q43820693 | ||
| Epstein-Barr virus replication in tongue epithelial cells | Q45729946 | ||
| Definition of the transcription factors which bind the differentiation responsive element of the Epstein-Barr virus BZLF1 Z promoter in human epithelial cells | Q45748838 | ||
| Epstein-Barr virus infection and replication in a human epithelial cell system | Q45880200 | ||
| p16 gene alterations in nasopharyngeal carcinoma | Q72220049 | ||
| P433 | issue | 50 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | overexpression | Q61643320 |
| P304 | page(s) | E3473-82 | |
| P577 | publication date | 2012-11-16 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells | |
| P478 | volume | 109 |
| Q110433109 | NP361-CDK4R24C-hTert |
| Q110433111 | NP361-cyclinD1-hTert |
| Q110433112 | NP361hTert |
| Q110433113 | NP446-CDK4R24C-hTert |
| Q110433114 | NP446-cyclinD1-hTert |
| Q54930966 | NP460hTert |
| Q110433115 | NP550-CDK4R24C-hTert |
| Q110433116 | NP550-cyclinD1-hTert |
| Q110433117 | NP550hTert |
| Q59357534 | A bacterial genotoxin causes virus reactivation and genomic instability in Epstein-Barr virus infected epithelial cells pointing to a role of co-infection in viral oncogenesis |
| Q41846150 | A new nasal cavity nursing methods application in patients with mechanical ventilation |
| Q38286857 | Cancer "causation" by infections--individual contributions and synergistic networks |
| Q35797164 | Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells |
| Q53089129 | Downregulation of PAK5 inhibits glioma cell migration and invasion potentially through the PAK5-Egr1-MMP2 signaling pathway. |
| Q47606332 | EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma. |
| Q55003883 | EBV based cancer prevention and therapy in nasopharyngeal carcinoma. |
| Q92998898 | EBV infection is associated with histone bivalent switch modifications in squamous epithelial cells |
| Q35027926 | Efficient immortalization of primary nasopharyngeal epithelial cells for EBV infection study |
| Q34712473 | Enhanced IL-6/IL-6R signaling promotes growth and malignant properties in EBV-infected premalignant and cancerous nasopharyngeal epithelial cells |
| Q90481053 | Epithelial cell infection by Epstein-Barr virus |
| Q51416588 | Epstein-Barr Virus Gene BARF1 Expression is Regulated by the Epithelial Differentiation Factor ΔNp63α in Undifferentiated Nasopharyngeal Carcinoma. |
| Q45324762 | Epstein-Barr Virus Hijacks DNA Damage Response Transducers to Orchestrate Its Life Cycle |
| Q40207035 | Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes. |
| Q56947843 | Epstein-Barr virus and nasopharyngeal carcinoma |
| Q40046633 | Epstein-Barr virus infection and nasopharyngeal carcinoma |
| Q38249886 | Epstein-Barr virus infection and persistence in nasopharyngeal epithelial cells |
| Q36124331 | Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin |
| Q38968588 | Epstein-Barr virus: more than 50 years old and still providing surprises. |
| Q58599820 | Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma |
| Q54109268 | Establishment of a nasopharyngeal carcinoma cell line capable of undergoing lytic Epstein-Barr virus reactivation. |
| Q37564524 | Extremely stringent activation of p16INK4a prevents immortalization of uterine cervical epithelial cells without human papillomavirus oncogene expression. |
| Q36812001 | Highly Efficient CRISPR/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains |
| Q58089548 | Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes |
| Q45288192 | Latent Membrane Protein 1 Is a Novel Determinant of Epstein-Barr Virus Genome Persistence and Reactivation |
| Q38191876 | Modes of infection and oncogenesis by the Epstein-Barr virus. |
| Q47286778 | Modulation of the Tumor Microenvironment by Epstein-Barr virus Latent Membrane Protein-1 in Nasopharyngeal Carcinoma. |
| Q38596356 | Nasopharyngeal Carcinoma: An Evolving Role for the Epstein-Barr Virus |
| Q86035551 | Nasopharyngeal carcinoma |
| Q52347943 | New Insights from Elucidating the Role of LMP1 in Nasopharyngeal Carcinoma. |
| Q36039869 | Overexpression of PIN1 Enhances Cancer Growth and Aggressiveness with Cyclin D1 Induction in EBV-Associated Nasopharyngeal Carcinoma |
| Q34346022 | PAK5-Egr1-MMP2 signaling controls the migration and invasion in breast cancer cell |
| Q88392173 | Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft models |
| Q40559290 | Pathogenesis: Infections causing gastric cancer |
| Q54978474 | Preclinical evaluation of ribociclib and its synergistic effect in combination with alpelisib in non-keratinizing nasopharyngeal carcinoma. |
| Q27021366 | Regulation of the latent-lytic switch in Epstein-Barr virus |
| Q38406478 | Reprint of: cancer "causation" by infections--individual contributions and synergistic networks |
| Q38724883 | Restricted TET2 Expression in Germinal Center Type B Cells Promotes Stringent Epstein-Barr Virus Latency |
| Q57176933 | Role of Epstein-Barr Virus in the Pathogenesis of Head and Neck Cancers and Its Potential as an Immunotherapeutic Target |
| Q92276560 | Strand-specific miR-28-3p and miR-28-5p have differential effects on nasopharyngeal cancer cells proliferation, apoptosis, migration and invasion |
| Q96304633 | Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma |
| Q35598260 | Telomerase activity impacts on Epstein-Barr virus infection of AGS cells |
| Q35875632 | The Epstein-Barr Virus BART miRNA Cluster of the M81 Strain Modulates Multiple Functions in Primary B Cells. |
| Q92860015 | The Global Landscape of EBV-Associated Tumors |
| Q38994418 | The Long and Complicated Relationship between Epstein-Barr Virus and Epithelial Cells |
| Q39003290 | The interaction between human papillomavirus and other viruses |
| Q38264787 | The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma |
| Q38253914 | The role of Epstein-Barr virus in epithelial malignancies |
| Q38440804 | The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma |
| Q91468424 | mTORC2-mediated PDHE1α nuclear translocation links EBV-LMP1 reprogrammed glucose metabolism to cancer metastasis in nasopharyngeal carcinoma |
| Q34023389 | miR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesis |
Search more.